Business Context and Reporting Period
This Form 6-K filing by Prana Biotechnology Limited (ASX: PBT) covers the month of April 2008. The registrant is a foreign private issuer based in South Melbourne, Australia. The filing serves as a notice under Section 708A(5) of the Corporations Act regarding the issuance of securities.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific corporate action involving share issuance.
- Securities Issued: 46,282 Ordinary Fully Paid Shares
- Issue Date: April 9, 2008
- Issue Price: $Nil
- Disclosure Status: Issued without disclosure to investors under Part 6D.2 of the Corporations Act
Material Changes
The primary material change reported is the increase in the company's share capital through the issuance of 46,282 shares at no cost. The company intends to apply to the Australian Stock Exchange Limited for quotation of these shares. No comparative financial data or prior period changes are included in this text.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. It confirms that the company has complied with Chapter 2M and Section 674 of the Corporations Act. No specific risks or contingencies are detailed beyond the regulatory notice of the share issuance.
Investor Verification Checklist
- Verify the total number of shares outstanding post-issuance to assess dilution impact.
- Confirm the purpose of the $Nil share issuance (e.g., employee compensation, capital restructuring) in subsequent filings.
- Check the status of the application for quotation of the new shares on the ASX.
- Review the company's latest Form 20-F for comprehensive financial data, as this 6-K does not contain financial statements.